Frandsen H
Institute of Toxicology, National Food Agency, Søborg, Denmark.
Carcinogenesis. 1997 Aug;18(8):1555-60. doi: 10.1093/carcin/18.8.1555.
The heterocyclic aromatic amines, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline (4,8-DiMeIQx) are formed during frying of meat. PhIP and 4,8-DiMeIQx have, after metabolic activation, been shown to form adducts with DNA at the C8 of guanine both in vitro and in vivo. In order to investigate possible urinary biomarkers for estimation of the genotoxic dose of PhIP and 4,8-DiMeIQx, [3H]PhIP-dG, [3H]PhIP-DNA and [14C]4,8-DiMeIQx-DNA were injected i.p. to rats and the excretion of radioactivity in urine and faeces were measured. For all three [3H]PhIP-dG, [3H]PhIP-DNA and [14C]4,8-DiMeIQx-DNA 15-20% of the dose were excreted in the urine and 80-85% of the dose were excreted in the faeces. Urinary excretion showed maximum to 24 h (90%) with a rapid decline, 10% to 48 h and 0% to 72 h. Faecal excretion also showed maximum to 24 h (60%) with a slower decline, 30% to 48 h and 10% to 72 h. HPLC analysis of samples of urine and extracts from faeces, from rats dosed with [3H]PhIP-dG, showed that approximately 90% of the radioactivity co-eluted with PhIP-dG, indicating that PhIP-dG is excreted unmetabolized. HPLC analysis of samples of urine and extracts from faeces, from rats dosed with [3H]PhIP-DNA, showed that approximately 85% of the radioactivity co-eluted with PhIP-dG, indicating that PhIP-DNA adducts is mainly excreted as nucleoside adducts. Approximately 5% of the radioactivity excreted in the urine co-eluted with PhIP-G, indicating loss of deoxyribose. HPLC analysis of samples of urine and extracts from faeces, from rats dosed with [14C]4,8-DiMeIQx-DNA, showed that approximately 90% of the radioactivity co-eluted with 4,8-DiMeIQx-dG, indicating that 4,8-DiMeIQx-DNA adducts is mainly excreted as nucleoside adducts. Man is able to eliminate compounds of a higher mol. wt in the urine than the rat, the percentage of PhIP-dG and 4,8-DiMeIQx eliminated in the urine of man would therefore be expected to be higher than in the rat. Measurement of urinary nucleoside adducts of PhIP and 4,8-DiMeIQx could therefore provide a basis for the development of a biomonitoring strategy for the genotoxic dose of these food derived HAA.
杂环芳香胺2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶(PhIP)和2-氨基-3,4,8-三甲基咪唑并[4,5-f]喹喔啉(4,8-二甲基喹喔啉)在肉类煎炸过程中形成。经代谢活化后,PhIP和4,8-二甲基喹喔啉已被证明在体外和体内均能在鸟嘌呤的C8位与DNA形成加合物。为了研究用于估计PhIP和4,8-二甲基喹喔啉遗传毒性剂量的潜在尿液生物标志物,将[3H]PhIP-dG、[3H]PhIP-DNA和[14C]4,8-二甲基喹喔啉-DNA腹腔注射到大鼠体内,并测量尿液和粪便中的放射性排泄物。对于所有三种物质,即[3H]PhIP-dG、[3H]PhIP-DNA和[14C]4,8-二甲基喹喔啉-DNA,15%-20%的剂量通过尿液排出,80%-85%的剂量通过粪便排出。尿液排泄在24小时达到最大值(90%),随后迅速下降,48小时时为10%,72小时时为0%。粪便排泄在24小时也达到最大值(60%),下降速度较慢,48小时时为30%,72小时时为10%。对用[3H]PhIP-dG给药的大鼠的尿液样本和粪便提取物进行HPLC分析,结果表明约90%的放射性与PhIP-dG共洗脱,这表明PhIP-dG以未代谢的形式排出。对用[3H]PhIP-DNA给药的大鼠的尿液样本和粪便提取物进行HPLC分析,结果表明约85%的放射性与PhIP-dG共洗脱,这表明PhIP-DNA加合物主要以核苷加合物的形式排出。尿液中排出的约5%的放射性与PhIP-G共洗脱,表明脱氧核糖流失。对用[14C]4,8-二甲基喹喔啉-DNA给药的大鼠的尿液样本和粪便提取物进行HPLC分析,结果表明约90%的放射性与4,8-二甲基喹喔啉-dG共洗脱,这表明4,8-二甲基喹喔啉-DNA加合物主要以核苷加合物的形式排出。人类能够比大鼠在尿液中排出更高分子量的化合物,因此预计人类尿液中排出的PhIP-dG和4,8-二甲基喹喔啉的百分比会高于大鼠。因此,测量PhIP和4,8-二甲基喹喔啉的尿液核苷加合物可为制定这些食物源性杂环胺遗传毒性剂量的生物监测策略提供依据。